AcquisitionsJul 1, 2026, 09:32 AM

Select Medical Acquired for $16.50/Share, Valued at $3.9B

AI Summary

Select Medical Holdings Corporation announced the completion of its acquisition by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). Shareholders received $16.50 per share in cash, valuing the company at approximately $3.9 billion. Following the acquisition, Select Medical's common stock will cease trading and be delisted from the New York Stock Exchange, while current officers will continue to lead the business. The transaction also involved an amendment to the Credit Agreement, establishing a new $1 billion incremental term loan.

Key Highlights

Select Medical acquired by consortium led by Robert A. Ortenzio, Martin F. Jackson, and WCAS.
Shareholders received $16.50 per share in cash for their Company Shares.
The acquisition values Select Medical at approximately $3.9 billion.
Select Medical's common stock will cease trading and delist from NYSE.
Current officers Robert A. Ortenzio and Martin F. Jackson will continue in their roles.
An incremental term loan of $1,000,000,000 was established under the Credit Agreement.
The purchase price represents an 18% premium over the unaffected share price.

View SEC Filing

SEM

Hospital/Nursing Management

SELECT MEDICAL HOLDINGS CORP

Price Impact